VEGF GENE Therapy (Biosidus SA)

N/A

Report date: 2022/03/14 18:05:38

Base Information

Drug NameVEGF GENE Therapy (Biosidus SA)
Drug Alias NameVascular endothelial growth factor gene therapy (Biosidus S.A.)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceAngiogenesis inducersVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosidus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosidus
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A